Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.68 |
| ▸ | GPR3 | P46089 | 2/20 | 0.68 |
| ▸ | CDK4 | P11802 | 1/20 | 0.67 |
| ▸ | CCND1 | P24385 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | AHR | P35869 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29558542 | 1.00 | ALDH1A1 (0.68) | ALDH1A1HSD17B10GPR3CDK4CCND1 | |
| SCHEMBL29814291 | 1.00 | ALDH1A1 (0.68) | ALDH1A1HSD17B10GPR3CDK4CCND1 | |
| SCHEMBL19770686 | 0.91 | CDK4 (0.75) | ALDH1A1HSD17B10GPR3CDK4CCND1 | |
| Carbazole SCHEMBL30761795 | 0.82 | ALDH1A1 (1.00) | ALDH1A1HSD17B10GPR3KMT2AHPGD | |
| Carbazole SCHEMBL29627417 | 0.82 | ALDH1A1 (1.00) | ALDH1A1HSD17B10GPR3KMT2AHPGD | |
| Carbazole SCHEMBL29355407 | 0.82 | ALDH1A1 (1.00) | ALDH1A1HSD17B10GPR3KMT2AHPGD | |
| Carbazole SCHEMBL370524 | 0.82 | ALDH1A1 (1.00) | ALDH1A1HSD17B10GPR3KMT2AHPGD | |
| Carbazole SCHEMBL7650 | 0.82 | ALDH1A1 (1.00) | ALDH1A1HSD17B10GPR3KMT2AHPGD | |
| Carbazole SCHEMBL30209164 | 0.82 | ALDH1A1 (1.00) | ALDH1A1HSD17B10GPR3KMT2AHPGD | |
| SCHEMBL21064780 | 0.82 | NPC1 (0.64) | ALDH1A1HSD17B10GPR3CDK4CCND1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4709853-A1 | METHODS OF PREVENTING ON-TARGET GENOTOXICITY INDUCED BY NUCLEASES | Institut National de la Santé et de la Recherche Médicale (FR) | 2026-03-18 | — | — | EP | disclosed |
| WO-2024235844-A1 | METHODS OF PREVENTING ON-TARGET GENOTOXICITY INDUCED BY NUCLEASES | Institut National de la Santé et de la Recherche Médicale (FR) | 2024-11-21 | — | — | WO | disclosed |
| US-11913884-B2 | Visible light-activated dyes and methods of use thereof | WILLIAM MARSH RICE UNIVERSITY (US) | 2024-02-27 | — | — | US | disclosed |
| US-11913884-B2 | Visible light-activated dyes and methods of use thereof | WILLIAM MARSH RICE UNIVERSITY (US) | 2024-02-27 | — | — | US | disclosed |
| WO-2023083465-A1 | A STABLE FORMULATION OF P2S5·2C5H5N | VIRONOVA THIONATION AB (SE) | 2023-05-19 | — | — | WO | disclosed |
| WO-2023083465-A1 | A STABLE FORMULATION OF P2S5·2C5H5N | VIRONOVA THIONATION AB (SE) | 2023-05-19 | — | — | WO | disclosed |
| EP-3718560-A2 | CYCLIN DEPENDENT KINASE INHIBITORS AND METHODS OF USE | The University of North Carolina at Chapel Hill (US) | 2020-10-07 | — | — | EP | disclosed |
| EP-3406260-B1 | CYCLIN DEPENDENT KINASE INHIBITORS AND METHODS OF USE | UNIV NORTH CAROLINA CHAPEL HILL (US) | 2020-09-23 | — | — | EP | disclosed |
| US-20200271587-A1 | VISIBLE LIGHT-ACTIVATED DYES AND METHODS OF USE THEREOF | WILLIAM MARSH RICE UNIVERSITY | 2020-08-27 | — | — | US | disclosed |
| CN-111378162-A | Energy absorption method based on dynamic polymer | 翁秋梅 | 2020-07-07 | — | — | CN | disclosed |
| US-4188359-A | CORROSION INHIBITION | PETROLITE CORPORATION (US) | 1980-02-12 | — | — | US | disclosed |
| US-4187277-A | Process of inhibiting corrosion with quaternaries of halogen derivatives of alkynoxymethyl amines | PETROLITE CORPORATION (US) | 1980-02-05 | — | — | US | disclosed |
| US-4146711-A | CORROSION INHIBITORS, MICROBIOCIDES | PETROLITE CORPORATION (US) | 1979-03-27 | — | — | US | disclosed |
| US-4146709-A | CORROSION INHIBITORS, MICROBIOCIDES | PETROLITE CORPORATION (US) | 1979-03-27 | — | — | US | disclosed |
| US-4120654-A | Alkynoxymethyl amines as corrosion inhibitors | PETROLITE CORPORATION (US) | 1978-10-17 | — | — | US | disclosed |
| US-4113709-A | Polyquaternary polythiazines | PETROLITE CORPORATION (US) | 1978-09-12 | — | — | US | disclosed |
| US-4101674-A | Halogen derivatives of alkynoxymethyl amines as microbiocides | PETROLITE CORPORATION (US) | 1978-07-18 | — | — | US | disclosed |
| US-4065260-A | Halogen derivatives of alkynoxymethyl amines as corrosion inhibitors | PETROLITE CORPORATION (US) | 1977-12-27 | — | — | US | disclosed |
| US-4026946-A | CORROSION INHIBITORS | PETROLITE CORPORATION (US) | 1977-05-31 | — | — | US | disclosed |
| US-4026807-A | CORROSION INHIBITORS | PETROLITE CORPORATION (US) | 1977-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200271587-A1 | VISIBLE LIGHT-ACTIVATED DYES AND METHODS OF USE THEREOF | HCCS, CLTB, ALDH1A2 | ALDH1A1 311/4885HSD17B10 3034/4885GPR3 2940/4885 |
| US-11913884-B2 | Visible light-activated dyes and methods of use thereof | HCCS, CLTB, ALDH1A2 | ALDH1A1 311/4885HSD17B10 3034/4885GPR3 2940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.